3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Terminated
2
Recruiting
2
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
10
Carcinoma, Hepatocellular
5
Colonic Neoplasms
4
Rectal Neoplasms
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Adenocarcinoma
2
Thrombocytosis
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Physician Education
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Noonan Syndrome 6
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma
1
MSI-H Colorectal Cancer
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Interventions
Sorafenib
12
Radiosurgery
5
Gemcitabine
5
Capecitabine
5
Bevacizumab
5
Radiotherapy
4
Fluorouracil
4
Doxorubicin
4
Sunitinib
3
Oxaliplatin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
seocalcitol
2
regorafenib
2
phosphomannopentaose sulfate
2
atezolizumab
2
Thiotepa
2
Radiofrequency Ablation
2
Melphalan
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Fluorodeoxyglucose F18
2
Filgrastim
2
Dexamethasone
2
Cisplatin
2
Chemoembolization, Therapeutic
2
Carboplatin
2
Busulfan
2
Brachytherapy
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Liver Neoplasms
×
regorafenib
×
Clear all
NCT04476329
2021-12-30
ReDos HCC
SC Liver Research Consortium, LLC
Phase 2
Terminated
7 enrolled
NCT03644511
2020-08-21
SORAGO-HCC
Bayer
Terminated
3 enrolled